Volibris ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

volibris

glaxosmithkline (ireland) limited - ambrisentan - hypertenzia, pľúca - antihypertenzív, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Violetta শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

violetta

gedeon richter plc., maďarsko - gestodén a etinylestradiol - 17 - anticoncipientia

LINDYNETTE 30 শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

lindynette 30

gedeon richter plc., maďarsko - gestodén a etinylestradiol - 17 - anticoncipientia

Lindynette 20 শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

lindynette 20

gedeon richter plc., maďarsko - gestodén a etinylestradiol - 17 - anticoncipientia

Sunya শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunya

heaton k.s., Česká republika - gestodén a etinylestradiol - 17 - anticoncipientia

Katya শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

katya

heaton k.s., Česká republika - gestodén a etinylestradiol - 17 - anticoncipientia